AI chatbot aims to soothe anxiety and depression in cannabis users

NCT ID NCT06920238

Recruiting now Symptom relief Sponsor: Trustees of Dartmouth College Source: ClinicalTrials.gov ↗

First seen Sep 30, 2025 · Last updated Jun 12, 2026 · Updated 28 times

Summary

This early-stage study tests whether a generative AI chatbot called Therabot-CALM is acceptable and helpful for people with cannabis use disorder who also have anxiety or depression. Fifteen participants will use the app for 4 weeks and give feedback through interviews and surveys. The goal is to see if the chatbot is easy to use and could improve symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

46 Centerra Parkway, Suite 300, Office #333S
RECRUITING

Lebanon, New Hampshire, 03766, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ANXIETY CANNABIS USE DISORDER DEPRESSION / MAJOR DEPRESSIVE DISORDER DEPRESSION, ANXIETY

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.

GENERALIZED ANXIETY DISORDER